HAVCR2 and leukemia: Up to now, numerous leukemia-associated aberrantly expressed markers have been recognized, including CD2, CD7, CD11b, CD22, CD33, CD44, CD45RA, CD56, CD123, CD366 (TIM3) and CD371 (Clec12A) [18–20].